Skip to main content
Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
105.35
+0.36 (0.34%)
At close: Nov 13, 2026, 4:00 PM EST
106.15
+0.80 (0.76%)
After-hours: Nov 13, 2026, 7:30 PM EST

Oruka Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Net Income
-152.57-105.43-91.34
Depreciation & Amortization
0.160.080.03
Loss (Gain) From Sale of Investments
-4.04-5-2.45
Stock-Based Compensation
27.524.2416.28
Other Operating Activities
0.60.461.74
Change in Accounts Payable
12.21-5.3210.35
Change in Other Net Operating Assets
-7.52.772.3
Operating Cash Flow
-123.64-88.21-63.09
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Capital Expenditures
-0.22-0.21-0.21
Investment in Securities
-606.59-96.54-359.93
Investing Cash Flow
-606.81-96.75-360.14

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Total Debt Issued
--27.25
Net Debt Issued (Repaid)
--27.25
Issuance of Common Stock
830.71170.32459.96
Financing Cash Flow
830.71170.32490.41

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Net Cash Flow
100.27-14.6467.17

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Free Cash Flow
-123.86-88.42-63.3
Free Cash Flow Growth
---
Free Cash Flow Per Share
-2.03-1.94-3.77
Levered Free Cash Flow
-91.81-55.83-
Unlevered Free Cash Flow
-91.81-55.83-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Change in Working Capital
4.71-2.5612.64
SEC Filings: 10-K · 10-Q